Weight Loss

Children with overweight or obesity had a short-term decrease in weight and BMI with professional-led interventions vs. standard care, but weight loss was not sustained long term, according to a study published in JAMA Network Open.

For young women who want to improve their aerobic fitness, weight loss may not matter, researchers found.

In this exclusive video, Barham Abu Dayyeh, MD, MPH, professor at Mayo Clinic, discussed results from a study that evaluated the incisionless weight loss procedure Pose 2.0 in patients who are obese or have obese-related comorbidities.

In this video, Erin O’Keefe, a medical student at the University of Miami Miller School of Medicine, discusses results of a study that investigated a potential association between aerobic capacity — measured by VO2 max — and long-term weight loss.

Improvement in aerobic capacity led to a greater percentage of weight loss in select populations, according to data scheduled to be presented at the ACP Internal Medicine Meeting.

Participants adhering to a calorie-restricted diet who exercised approximately 1.5 hours per week for 1 year had about the same amount of weight loss as those on the same diet who exercised nearly 4 hours per week, according to research presented at Nutrition 2020.

Losing weight from young adulthood into midlife is associated with a substantially reduced risk for arthritis, according to data published in Arthritis Care & Research.

Among nearly half a million adults from the United States and Canada who underwent weight-loss surgery, those with lower presurgical BMI and those who lost even a small amount of weight before the procedure were less likely to die within 30 days, according to findings published in JAMA Network Open.

Adults with obesity who wore a heavyweight vest — corresponding to 11% of their body weight — daily for 3 weeks experienced a reduction in body weight and fat mass compared with similar adults who wore a 1% lightweight vest, according to data from a proof-of-concept study.

The FDA on Monday issued a Letter to Health Care Providers detailing risks for hyperinflation and acute pancreatitis observed in post-approval studies for two liquid-filled intragastric balloons indicated for weight loss, both approved in 2015 and manufactured by Apollo Endosurgery.